link: http://ift.tt/1MJldsy
Hot And Trending...
Trending
- Gold Scarcity in Perspective as "Peak Gold" Looms @SchiffGold http://t.co/bwWA5ADRgn
- It’s Time to Give a Little Thought to Silver https://t.co/6dgAkpzwVk @SchiffGold
- The Fed continues to suggest it wants to raise rates, but the reality is it can't. https://t.co/vpct5j2EzF
- Dow Jones down 6% from its highs & falling fast. How much more will it fall before the Fed stops pretending the data supports a rate hike?
- Had the same 2% inflation assumption used to calculate Q1 #GDP been applied to Q2, the reported growth rate would have been just 1.6%!
- To save the stock market while pretending the "recovery" in still on track, the #Fed used low oil prices as its excuse to turn more dovish.
- The tax code itself creates incentives, and tax cuts can help change those incentives in positive ways that boost growth. http://bit.ly/2B7pwia
- Malinvestment and the Austrian Business Cycle, as explained by Yogi Berra
- Khrushchev: Economics Does Not Respect One's Wishes
- If #Trump really wants to reduce America's trade deficit he needs to slash regulations and massively reduce government spending, including entitlements. That will free up resources to investment in plant, equipment and worker training that will improve our global competitiveness.
Wednesday, September 23, 2015
I'm sure you've heard of Daraprim, the drug whose price skyrocketed recently...
...After the rights to sell it under that name were bought. What I'm wondering is why the price has skyrocketed without significant government intervention. Or is the right to sell under that name enough to keep competition out? Seems implausible. Presumably, competition would decrease the price, so what's keeping entrants from the market?